Lv1
60 积分 2024-12-03 加入
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
2个月前
已完结
MicroRNAs as Promising Biomarkers for Diagnosing Human Cancer
2个月前
已完结
Modulating G6PD/PGD to overcome FSP1/DHODH‐mediated ferroptosis defence: A novel oridonin derivative suppresses liver cancer
3个月前
已完结
Immunotherapies for hepatocellular carcinoma
4个月前
已完结
The SMARCA4R1157W mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
5个月前
已完结
DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition
7个月前
已完结
DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition
7个月前
已完结
DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition
8个月前
已完结
皖公网安备34019202002308
